Coronavirus
Moderna’s US Coronavirus Vaccine Trial Finished Enrolling All 30,000 Participants
(CNN)Moderna, the first company to start US clinical trials of a Covid-19 vaccine, on Thursday finished enrolling all 30,000 of its participants.
All 30,000 have received their first shot, and most of them have also received the required second shot.
The company’s president says it’s now on track to apply to the US Food and Drug Administration for authorization to put the vaccine on the market in early December “if all the stars align.”
Dr. Stephen Hoge, Moderna’s president, said enrolling 30,000 participants is “just a milestone — it’s not the mission.” Half of the participants received the vaccine and half received a placebo, or a shot of saline that does nothing. The participants receive a second shot four weeks later.
